Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Once-nightly oxybate dosing preference and nocturnal experience with twice-nightly oxybates: a plain language summary of publication.
Journal: Expert review of neurotherapeutics
Published: May 21, 2026
Cardiovascular and cardiometabolic comorbidities in central disorders of hypersomnolence: A narrative review.
Journal: Sleep medicine reviews
Published: January 16, 2026
Mazindol Immediate-Release/Sustained-Release (IR/SR): A 50-Year Legacy of Multifaceted Mechanisms and Emerging Therapeutic Potential.
Journal: Clinical drug investigation
Published: May 01, 2025
Atomoxetine and spironolactone combine to reduce obstructive sleep apnea severity and blood pressure in hypertensive patients.
Journal: Sleep & breathing = Schlaf & Atmung
Published: March 18, 2024
Cataplexy response with extended-release once-nightly sodium oxybate: Post hoc responder analyses from the phase 3 REST-ON clinical trial.
Journal: Sleep medicine: X
Published: January 23, 2024
The Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea (MARIPOSA): A Randomized Controlled Trial.
Journal: American journal of respiratory and critical care medicine
Published: October 09, 2023
Effects of atomoxetine plus a hypnotic on obstructive sleep apnea severity in patients with a moderately collapsible pharyngeal airway.
Journal: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
Published: February 03, 2023
Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial.
Journal: CNS drugs
Published: January 23, 2022
Preferences for Attributes of Sodium Oxybate Treatment: A Discrete Choice Experiment in Patients with Narcolepsy.
Journal: Patient preference and adherence
Published: December 23, 2021
Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy.
Journal: Sleep
Published: May 14, 2021
A randomized study of solriamfetol for excessive sleepiness in narcolepsy.
Journal: Annals of neurology
Published: July 27, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026